Evidence map›Paper›PMID 38861104›Full record

ArticleDiscover oncology2024

Acute promyelocytic leukemia in children cancer hospital Egypt.

Samah Semary, Mahmoud Hammad, Dina Yassin, Nahla El Sharkawy, Sonya Soliman, Sherine Salem, Emad Ezzat, Ahmed Mosa, Sonia Ahmed

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Discover oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Samah SemaryDepartment of Clinical Oncology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt. samahsemary@yahoo.com.ORCID https://orcid.org/0000-0002-5394-3307
Mahmoud HammadDepartment of Pediatric Oncology, Children's Cancer Hospital Egypt (CCHE-57357), Cairo, Egypt.
Dina YassinDepartment of Clinical Pathology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt.
Nahla El SharkawyDepartment of Clinical Pathology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt.
Sonya SolimanDepartment of Clinical Pathology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt.
Sherine SalemDepartment of Clinical Pathology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt.
Emad EzzatDepartment of Clinical Pharmacy, Children's Cancer Hospital Egypt (CCHE-57357), Cairo, Egypt.
Ahmed MosaDepartment of Clinical Research, Children's Cancer Hospital Egypt (CCHE-57357), Cairo, Egypt.
Sonia AhmedDepartment of Pediatric Oncology, Children's Cancer Hospital Egypt (CCHE-57357), Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPediatric acute promyelocytic leukemia (APL) accounts for 5 to 15% of all myelocytic leukemia. A retrospective analysis of pediatric patients diagnosed and treated with APL was conducted at CCHE from July 2012 to the end of December 2019, to report the prevalence, clinical characteristics, results, and risk factors associated with induction failure and early death.

resultSixty-two patients were reported, with an age greater than ten, an initial poor coagulation profile, and a total leukocyte count (TLC) greater than 30 10

conclusionPediatric APL outcomes are influenced by age above 10, an initial poor coagulation profile, and a promyelocyte count of more than 10%. An initial leukocyte count of more than 10 × 10

Indexed as

Acute myeloid leukemiaAcute promyelocytic leukemiaAll-trans retinoic acidDifferentiation syndromeTranslocation (15, 17)

Identifiers

PMID38861104
PMCPMC11166612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.